BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12962049)

  • 1. [Neuroprotective and cerebrovascular effects of GABA mimetics].
    Mirzoian RS
    Eksp Klin Farmakol; 2003; 66(2):53-6. PubMed ID: 12962049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone].
    Lun'shina EV; Gan'shina TS; Makarova LM; Pogorelyĭ VE; Mirzoian RS
    Eksp Klin Farmakol; 2003; 66(1):20-2. PubMed ID: 12683075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection of gamma-aminobutyric acid receptor agonists via enhancing neuronal nitric oxide synthase (Ser847) phosphorylation through increased neuronal nitric oxide synthase and PSD95 interaction and inhibited protein phosphatase activity in cerebral ischemia.
    Zhou C; Li C; Yu HM; Zhang F; Han D; Zhang GY
    J Neurosci Res; 2008 Oct; 86(13):2973-83. PubMed ID: 18512761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a drug composition containing pyroglutamic acid and pyrrolidone on the cerebral circulation].
    Lun'shina EV; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2002; 65(3):3-5. PubMed ID: 12227092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gabaergic mechanism of cerebrovascular and neuroprotective effects of afobazole and picamilon].
    Silkina IV; Gan'shina TC; Seredin SB; Mirzoian RS
    Eksp Klin Farmakol; 2005; 68(1):20-4. PubMed ID: 15786959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia.
    Schwartz-Bloom RD; Sah R
    J Neurochem; 2001 Apr; 77(2):353-71. PubMed ID: 11299298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebrovascular and antiaggregative effects of GABA-docosahexaenoyldopamine conjugate].
    Kurdiumov IN; Gan'shina TS; Mirzoian NR; Vasil'eva TM; Makarov VA; Petrukhina GN; Bezuglov VV; Gretskaia NM; Zinchenko GN; Mirzoian RS
    Eksp Klin Farmakol; 2008; 71(4):26-9. PubMed ID: 18819437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The neuroprotective effect of GABA-ergic substances in cerebral ischemia].
    Kulinskiĭ VI; Mikhel'son GV
    Eksp Klin Farmakol; 1997; 60(1):56-8. PubMed ID: 9162288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-aminobutyric acid modulates local brain oxygen consumption and blood flow in rat cerebellar cortex.
    Caesar K; Offenhauser N; Lauritzen M
    J Cereb Blood Flow Metab; 2008 May; 28(5):906-15. PubMed ID: 18000512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebrovascular effects of GABA-prostaglandin E2 conjugate in comparison with prostaglandin E2].
    Gorbunova AV; Gan'shina TS; Gretskaia NM; Bezuglov VV; Mirzoian RS
    Eksp Klin Farmakol; 2013; 76(8):13-6. PubMed ID: 24228482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The action of emoxipin, lithium oxybutyrate and pikamilon on the blood circulation of the ischemic brain].
    Pogorelyĭ VE; Gaevyĭ MD
    Eksp Klin Farmakol; 1999; 62(6):26-8. PubMed ID: 10650522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. gamma-Aminobutyric acid system in cardiovascular and cerebrovascular function.
    Roberts E; Krause DN
    Isr J Med Sci; 1982 Jan; 18(1):75-81. PubMed ID: 7040301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of lithium derivatives of GABA on blood circulation and metabolic indices in the brain under ischemia].
    Pogorelyĭ VE; Gaevyĭ MD; Migruev RR; Ivashev MN
    Eksp Klin Farmakol; 1995; 58(5):19-21. PubMed ID: 8704581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/gamma-aminobutyric acid release and biosynthesis.
    Dave KR; Lange-Asschenfeldt C; Raval AP; Prado R; Busto R; Saul I; Pérez-Pinzón MA
    J Neurosci Res; 2005 Dec; 82(5):665-73. PubMed ID: 16247804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peculiarities of cerebrovascular effects of GABA conjugate with docosahexaenoyl dopamine under conditions of separate and combined vascular pathology of brain and heart].
    Mirzoian RS; Gan'shina TS; Khaĭlov NA; Kurdiumov IN; Lebedeva MA; Gretskaia NM; Bezuglov VV
    Eksp Klin Farmakol; 2012; 75(7):15-9. PubMed ID: 23025047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of GABA isonicotinoylamide on cerebral circulation].
    Mirzoian RS; Gan'shina TS; Shmuĭlovich LM
    Biull Eksp Biol Med; 1981 Nov; 92(11):573-4. PubMed ID: 7317636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Participation of the GABA system in tha adaptive rearrangement of the cerebral circulation in hypokinesia].
    Akopian VP
    Eksp Klin Farmakol; 2003; 66(3):4-8. PubMed ID: 12924223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive neuroprotection of GABA A and GABA B receptor agonists in cerebral ischemic injury via PI-3K/Akt pathway inhibiting the ASK1-JNK cascade.
    Xu J; Li C; Yin XH; Zhang GY
    Neuropharmacology; 2008 Jun; 54(7):1029-40. PubMed ID: 18410948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced activity of GABA receptors inhibits glutamate release induced by focal cerebral ischemia in rat striatum.
    Ouyang C; Guo L; Lu Q; Xu X; Wang H
    Neurosci Lett; 2007 Jun; 420(2):174-8. PubMed ID: 17531382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
    Wang CX; Ding X; Shuaib A
    Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.